Skip to main navigation Skip to search Skip to main content

When is it Appropriate to Lower Low Density Lipoprotein-Cholesterol Levels to <30 mg/dL?

Research output: Contribution to journal › Editorial › peer-review

Original languageEnglish (US)
Pages (from-to)142-144
Number of pages3
JournalAmerican Journal of Cardiology
Volume157
DOIs
StatePublished - Oct 15 2021

Funding

Dr. Wong has received research support through his institution from Novartis and Esperion and is also a consultant for Novartis. Dr Duell as served as an advisor and/or has received institutional grants from: Akcea, Amryt, Esperion, Regeneron, Regenxbio, and Retrophin/Travere. Dr. Mehta has received institutional research grants from Amgen, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Torrent. Dr Puri does not report any potential conflicts of interest.

Funders
Amgen
AstraZeneca
Boehringer-Ingelheim

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine

    Cite this